Global Rapid Influenza Diagnostic Test (RIDT) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Rapid Influenza Diagnostic Test (RIDT) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Rapid Influenza Diagnostic Test (RIDT) market size was valued at US$ 971 million in 2023 and is forecast to a readjusted size of USD 1888 million by 2030 with a CAGR of 9.7% during review period.

In China, the key players of Rapid Influenza Diagnostic Test (RIDT) include Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Abbott, etc. The top three players hold a share of more than 61 percent. In terms of product type, Conventional RIDT is the largest segment, occupied for 92 percent. And in terms of application, hospital is the largest application, with a share of 65%.

This report is a detailed and comprehensive analysis for global Rapid Influenza Diagnostic Test (RIDT) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Rapid Influenza Diagnostic Test (RIDT) market size and forecasts, in consumption value ($ Million), 2019-2030

Global Rapid Influenza Diagnostic Test (RIDT) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Rapid Influenza Diagnostic Test (RIDT) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Rapid Influenza Diagnostic Test (RIDT) market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Rapid Influenza Diagnostic Test (RIDT)

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Rapid Influenza Diagnostic Test (RIDT) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Quidel, Actim, Denka, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, Daan Gene, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Rapid Influenza Diagnostic Test (RIDT) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Rapid Influenza Diagnostic Test (RIDT) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Digital RIDTs
Conventional RIDT

Market segment by Application
Hospital
POCT
Others

Market segment by players, this report covers
Abbott
Quidel
Actim
Denka
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
Daan Gene

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Rapid Influenza Diagnostic Test (RIDT) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Rapid Influenza Diagnostic Test (RIDT), with revenue, gross margin, and global market share of Rapid Influenza Diagnostic Test (RIDT) from 2019 to 2024.

Chapter 3, the Rapid Influenza Diagnostic Test (RIDT) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Rapid Influenza Diagnostic Test (RIDT) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Rapid Influenza Diagnostic Test (RIDT).

Chapter 13, to describe Rapid Influenza Diagnostic Test (RIDT) research findings and conclusion.